July 10, 2016 to July 15, 2016
Snow King Lodge, Jackson Hole, Wyoming
Adam Bagg, M.D.
Dr. Adam Bagg is director of hematology and medical director of clinical cancer cytogenetics at the University of Pennsylvania where he is a professor of pathology and laboratory medicine, in the division of hematopathology (for which he served as Interim Director until June 2015). For the past five years he was voted by his peers as one of Philadelphia’s Top Doctors. Per US News & World Report he is in the top 1% of doctors in the United States. In 2011, he was elected to the USCAP Board of Directors, having previously served on the Education Committee. He lectures extensively nationally (at USCAP, ASCP, AMP, CAP, ACLPS, AACC, ISLH and ASH) and internationally (United Kingdom, Germany, India, China, South Korea, Singapore, South Africa, Brazil, Lebanon, Canada, Mexico, Sudan, Turkey and Romania). Most of his more than 140 publications are on the molecular pathology of hematologic malignancies. A publication that he co-authored (CART19 T-cells to treat CLL) was the most downloaded article in Science Translational Medicine for 2011. He is an Associate Editor of the Journal of Molecular Diagnostics and on the Editorial Board of Advances in Anatomic Pathology.
Thomas V. Colby, M.D.
Dr. Colby was born in Massachusetts and educated at Tulane University, Stanford University, and the University of Michigan, receiving his M.D. in 1974. He did his residency and a stint on Faculty at Stanford University Medical Center as Assistant Professor until 1983. He then moved to the University of Utah where he was Associate Professor and the Director of Surgical Pathology for three and a half years before relocating to Mayo Clinic in Rochester, MN in 1986. He has been a Professor of Pathology since 1989. In 1993 he moved to Mayo Clinic in Arizona. In 2007 he was named the Geraldine C. Zeiler Professor of Cytopathology, and as a result of the monies from this professorship over 50 “Zeiler Fellows” from around the world have come to Mayo Arizona to learn pulmonary pathology and/or cytopathology.
Dr. Colby developed an interest in pulmonary pathology while working with Dr. Charles Carrington at Stanford University. Dr. Carrington was one of Dr. Averill Liebow’s star pupils in lung pathology. Dr. Colby inherited Dr. Carrington’s teaching collection and has added considerably to it. It now comprises some 20,000 cases of lung pathology specimens available for study and review at Mayo Clinic in Arizona. Over 200 individuals from all corners of the earth have come to review this collection.
Dr. Colby maintains an active consultation practice in concert with Drs. H.D. Tazelaar, M.L. Smith, and K.O. Leslie and among them they see some 5,000 lung pathology consultations per year.
Dr. Colby has lectured widely since 1979 and has over 420 peer-reviewed publications.
Wendy Frankel, M.D.
Wendy Frankel, M.D. is distinguished professor of pathology, chair and director of anatomic pathology at The Ohio State University, Wexler Medical Center. She is also the director of the division of gastrointestinal (GI) pathology and the GI/Liver Pathology Fellowship at OSU. Dr. Frankel earned her M.D. from the University of Michigan Medical School in Ann Arbor, Michigan. She spent five years as a resident and research fellow in the Department of Surgery, Hospital of the University of Pennsylvania in Philadelphia. Dr. Frankel then went on to complete a residency in Anatomic and Clinical Pathology in the Department of Pathology, University of California, San Diego followed by a Surgical Pathology Fellowship at the University of California, San Francisco. She is past-president of the Rodger C. Haggitt GI Pathology Society and serves on the USCAP Executive Committee. Her research is centered on colorectal cancer genetics with focus on the Lynch Syndrome.
David B. Kaminsky, M.D., FIAC
Dr. Kaminsky is a career cytopathologist and surgical pathologist who now serves as the USCAP Executive Vice President. His patient-centered private practice in Palm Springs, California, focused on surgical pathology and ultrasound-guided fine needle aspiration biopsy. Dr. Kaminsky was a pioneer in aspiration biopsy and published Aspiration Biopsy for the Community Hospital in 1981,which facilitated use of the technique outside restricted academic centers. He has lectured internationally on the subject and is the 2015 recipient of the Yolanda Oertel Interventional Cytopathologist of the Year Award of the Papanicolaou Society. He has been president of the American Society of Cytopathology and recipient of its distinguished Papanicolaou Award. His interests outside medicine include documentary film-making (short doc Academy Award Nomination, personal Emmy Nomination, Telly) foreign films (Italian cinema) and culinary arts.
Esther Oliva, M.D.
Dr. Esther Oliva is professor of pathology at Harvard Medical School, and pathologist at the Massachusetts General Hospital, Boston. Her work is mainly focused on neoplastic diseases involving the female genital tract (with a particular interest in mesenchymal tumors) and the genitourinary tract. Dr. Oliva has been a regularly invited speaker at all major national and international pathology meetings and serves on the editorial boards of the American Journal of Surgical Pathology, Archives of Pathology and Laboratory Medicine, Human Pathology, International Journal of Gynecologic Pathology, Advances in Anatomic Pathology, Modern Pathology, Seminars in Diagnostic Pathology, and Pathology (Australia). She was a member of the USCAP Executive Committee and she is currently the secretary of the International Society of Gynecological Pathologists. Dr Oliva is co-editor of the book "Gynecologic Pathology" (Foundations in Diagnostic Pathology series), editor of the monograph "Current Concepts in Gynecologic Pathology: Mesenchymal Tumors of the Female Genital Tract" (part of Surgical Pathology Clinics), and co-editor of "Diagnostic Pathology Gynecologic" from Amirsys. She co-directed the USCAP long course in 2015 on uterine pathology with Dr Marisa Nucci and has participated in four USCAP short courses (one still on-going).
Brian Rubin, M.D., Ph.D.
Dr. Brian Rubin is professor of pathology, vice-chair of rResearch within the Robert J. Tomsich Pathology and Laboratory Medicine Institute, and director of soft tissue pathology at the Cleveland Clinic. He received his Ph.D. in molecular biology and his M.D. degree from Cornell University Medical College. He did his residency in anatomic pathology at Brigham and Women’s Hospital and received fellowship training in soft tissue pathology, bone pathology, and cancer genetics.
Dr. Rubin has dedicated his career to a better understanding of the diagnosis and classification of soft tissue neoplasms, especially sarcomas, where he is a prominent figure nationally and internationally. He is widely regarded as a thought leader in the field and is a founding member of the International Society of Bone and Soft Tissue Pathology. His laboratory is focused on understanding the pathogenesis of sarcomas with the major aim of developing targeted therapies. Dr. Rubin has published over 150 peer reviewed journal articles and is the author of numerous reviews and book chapters. He was a member of the working group that authored the WHO Classification of “Tumours of Bone and Soft Tissue” in 2002 and 2013. He is well known for his work on gastrointestinal stromal tumor (GIST) and other cancers (such as melanoma) that are driven by oncogenically-activated KIT receptor tyrosine kinase. His group also characterized a novel gene fusion in epithelioid hemangioendothelioma (EHE), a sarcoma with endothelial differentiation. This latest development has allowed them to initiate studies of EHE biology with the goal of developing targeted therapies to treat EHE.
John Srigley, M.D., FRCPC, FRCPath, FRCPA (Hon.)
Dr. Srigley is a graduate of the faculty of medicine, University of Toronto, who undertook postgraduate training in anatomic and oncologic pathology at the University of Toronto and MD Anderson Cancer Centre in Houston. Dr. Srigley has practiced surgical and urologic pathology for over 30 years and is currently the chief and medical director of the program of laboratory medicine and genetics at Trillium Health Partners, one of the largest community-academic hospitals in Canada. He is also a professor in the department of pathology and molecular medicine at McMaster University. Dr. Srigley is an international consultant and educator in surgical and urologic pathology and has contributed extensively to the literature. He is an editor/author of three textbooks on urological pathology including the series 3 AFIP Fascicle on “Tumors of the Prostate Gland”. Dr. Srigley has been an author and member of the international working groups for the 2004 and 2016 WHO Bluebooks on “Tumors of the Urinary System and Male Genital Organs”. He is the Canadian representative on the American Joint Committee on Cancer and a member of the AJCC male genital system expert panel. Dr. Srigley is a past-president of the International Society of Urological Pathologists (ISUP) and the Ontario Association of Pathologists. His research interests include clinical-pathological and translational studies of urological cancer, population-level quality initiatives in cancer pathology and the role of the pathologist in cancer control. Dr. Srigley is also a founding board member of the International Collaboration on Cancer Reporting (ICCR) and has provided advice on population-level standardized cancer pathology reporting to the College of American Pathologists as well as groups in Australasia, Poland, Norway and Brazil.
Daniel W. Visscher, M.D.
Dr. Visscher is a consultant in anatomic pathology at Mayo Clinic, where he has practiced since 2010. Prior to this appointment he was a professor of pathology at the University of Michigan and Wayne State University. He is a general pathologist and has rotated on frozen section, cytology, autopsy and biopsy services for over 25 years. At Mayo Clinic, Dr. Visscher also participates in a subspecialty practice of breast pathology, which accessions several thousand consultations per annum on difficult or unusual specimens. His curriculum vitae lists over 200 publications in the field of breast pathology, which are oriented toward new diagnostic entities, application of biomarkers in classification/prognosis and, especially, the pathology of early breast cancer, in particular the significance/classification of benign “fibrocystic” breast diseases and atypias. His most recent work explores the importance of lobular involution to breast cancer pathogenesis and development of gene signatures to predict and “individualize” breast cancer risk.
Dr. Visscher is a fitness enthusiast who is a life-long runner. He is an avid gardener.
Bruce M. Wenig, M.D.
Dr. Bruce Wenig is chairman of diagnostic pathology and laboratory medicine at Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai Roosevelt, and the vice chairman for anatomic pathology in the Mount Sinai Health System New York, NY. He is board certified in anatomic and clinical pathology having completed his residency training in the department of pathology at the Mount Sinai Medical Center New York, NY (1981-1985). Following his residency training, Dr. Wenig completed a fellowship in surgical pathology at the Cedars Sinai Medical Center in Los Angeles, CA (1985-1986) and a fellowship in otolaryngic pathology at the Armed Forces Institute of Pathology in Washington, DC (1986-1987). Following his fellowship training, Dr. Wenig was a staff pathologist in the department of otorhinolaryngic and endocrine pathology at the Armed Forces Institute of Pathology (1987-1998), and served as the division chief for otorhinolaryngic pathology. From 1998-2001, he was the vice chairman for anatomic pathology in the department of pathology at the Albert Einstein College of Medicine Bronx, N.Y. and then vice chairman for anatomic pathology in the department of pathology and laboratory medicine at Continuum Health Partners. Dr. Wenig’s main clinical interests are in diseases of the head and neck, and endocrine organs. Dr. Wenig has published extensively in peer-reviewed journals, authored numerous book chapters and edited several textbooks on head and neck, and endocrine pathology.
Rhonda K. Yantiss, M.D.
Dr. Yantiss received her undergraduate degree from the University of Kansas and graduated from Harvard Medical School. She completed her residency in anatomic pathology at the Massachusetts General Hospital, followed by fellowship training in gastrointestinal and liver pathology at the Beth Israel Deaconess Medical Center. She is currently a Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College where she is the director of the gastrointestinal and liver pathology service. Dr. Yantiss has chaired the Nominations and Education Committees of the Rodger C. Haggitt Gastrointestinal Pathology Society and served as President of that society. She is a current member of the Education Committee and prior member of the Ramzi Cotran Investigator Award Committee of the United States and Canadian Academy of Pathology. Dr. Yantiss lectures widely in the United States and abroad and is the Course Director of the Tutorial on Pathology of the GI Tract, Pancreas, and Liver. She has received several teaching and professional awards, including the Arthur Purdy Stout Society of Pathology Annual Prize. Dr. Yantiss has published more than 150 articles, books, and book chapters related to gastrointestinal pathology. She serves as an ad hoc reviewer for fifteen journals and member of the editorial boards of the Archives of Pathology and Laboratory Medicine, Modern Pathology, American Journal of Clinical Pathology, Seminars in Diagnostic Pathology, and The American Journal of Surgical Pathology; she is also an Associate Editor of Archives of Pathology and Laboratory Medicine.